Search Within
Document Type
8067-24-1
Applied Filters:
Keyword:'8067-24-1'
Showing 1-13 of 13 results for "8067-24-1" within Technical Documents
GUINEA PIG ANTI-P2X2 RECEPTOR
distribution of two ATP-gated channels (P2X
receptors) determined by immunocytochemistry. PNAS.USA 93:8063-8067.
Vulchanova, L., et al., (1997) Immunohistochemical study of the P2X2 and P2X3 receptor
subunits
Data Sheet - D8815
al., Mol. Biol. Cell, 13, 183-194
(2002).
7. Kanamori, T., et al., J. Biol. Chem., 270, 8061-
8067, (1995).
8. Saito, T., et al., Exp. Cell Res., 212, 49-61 (1994).
9. Amano, T., et al., Biochem. J
Data Sheet - D8940
, Mol. Biol. Cell, 13, 183-194
(2002).
7. Kanamori, T., et al., J. Biol. Chem., 270, 8061-
8067, (1995).
8. Saito, T., et al., Exp. Cell Res., 212, 49-61 (1994).
9. Amano, T., et al., Biochem.
Protocol- HCVD4MAG-67K
Lyophilized 1 vial HCVMG4-8067-4
Human CVD Panel 4 Quality
Controls 1 and 2
Lyophilized 2 vials HCVMG4-6067-4
Set of one 96-Well Plate with 2 sealers - 1 set -
Serum
Protocol: MILLIPLEX®Human Cardiovascular Disease (CVD) Magnetic Bead Panel 1
CVD Panel 1 Standard Lyophilized 1 vial HCVMG1-8067-1
Human CVD Panel 1 Quality
Controls 1 and 2
Lyophilized 2 vials HCVMG1-6067-1
Set of one 96-Well Plate with
Protocol- HCVD2MAG-67K
Lyophilized 1 vial HCVMG2-8067-2
Human CVD Panel 2 Quality
Controls 1 and 2
Lyophilized 2 vials HCVMG2-6067-2
Set of one 96-Well Plate
with 2 sealers
- 1 set -
Protocol- HCVD3MAG-67K
Lyophilized 1 vial HCVMG3-8067-3
Human CVD Panel 3 Quality
Controls 1 and 2
Lyophilized 2 vials HCVMG3-6067-3
Bead Diluent 3.5 mL 1 vial LBD
Set of one 96-Well Plate with 2
Protocol- HCVD6MAG-67K
Lyophilized 1 vial HCVMG6-8067-6
Human CVD Panel 6 Quality
Controls 1 and 2
Lyophilized 2 vials HCVMG6-6067-6
Bead Diluent 3.5 mL 1 vial LBD-4
Set of one 96-Well Plate with 2
Protocol: Human Cardiovascular Disease Panel 4 Magnetic Bead Panel
Standard HCVMG4-8067-4 Lyophilized 1 vial
Human CVD Panel 4 Quality Controls 1
and 2
HCVMG4-6067-4 Lyophilized 2 vials
Set of one 96-Well Plate with 2 sealers ----------- -----------
1 plate
Celltransmissions Newsletter
cavernosum
cGMP
PKA
PKG
cGMP
Dipyridamole (D 9766)
DMPPO
Sildenafil (Viagra)
T-0156 (T 8067)
T-1032 (T 7692)
Tadalafil (Cialis)
Vardenafil (Levitra)
Zaprinast (Z 0878)
0.90 [2]
0.003 [
Human Cardiovascular Disease Magnetic Bead Panel 5
HCVMG5-8067-5 Lyophilized 1 vial
Human CVD Panel 5 Quality Controls 1 and
2
HCVMG5-6067-5 Lyophilized 1 vial each
Serum Matrix
Note: Contains 0.08% Sodium Azide
MXHSM-14 Lyophilized 1 vial
Protocol: Human Cardiovascular Disease (CVD) Panel 2 Magnetic Bead Kit
HCVMG2-8067-
2
lyophilized 1 vial
Human CVD Panel 2 Quality Controls 1
and 2
HCVMG2-6067-
2
lyophilized 2 vials
Set of one 96-Well Plate with 2 sealers ----------- -----------
1 plate
Protocol: Human Cardiovascular Disease (CVD) Panel 3 (Acute Phase)
Human CVD Panel 3 Standard HCVMG3-8067-3 lyophilized 1 vial
Human CVD Panel 3 Quality Controls 1
and 2
HCVMG3-6067-3 lyophilized 2 vials
Bead Diluent LBD 3.5 mL 1 vial
Set of one